Related Experiment Video
Updated: Aug 6, 2026

Angle-resolved Photoemission Spectroscopy At Ultra-low Temperatures
Published on: October 9, 2012
Cardiovascular complications secondary to Graves' disease: a prospective study from Ukraine
Iryna Tsymbaliuk1, Dmytro Unukovych2, Nataliia Shvets1
1Department of Therapy, Shupyk National Medical Academy of Postgraduate Education, 04112 Kiev, Ukraine; Department of Functional Diagnostic, Kyiv City Teaching Endocrinological Center, 01034 Kiev, Ukraine.
Insights
Restoring euthyroid state in Graves' disease patients significantly reduces cardiovascular issues and improves quality of life. This study highlights the positive impact of thyroid normalization on thyrotoxic heart disease patients.
Area of Science:
- Cardiology
- Endocrinology
- Quality of Life Research
Background:
- Graves' disease (GD) is a leading cause of hyperthyroidism.
- Hyperthyroidism can lead to thyrotoxic heart disease (THD).
Purpose of the Study:
- To assess cardiovascular complications in patients with THD secondary to GD.
- To evaluate health-related quality of life (HRQoL) in these patients.
Main Methods:
- Clinical assessment of 61 patients with THD secondary to GD before and after achieving a euthyroid state.
- HRQoL assessment using the EQ-5D-5L questionnaire in 30 patients.
- Statistical analysis to determine the impact of treatment on cardiovascular parameters and HRQoL.
Main Results:
- Significant reductions in resting heart rate, blood pressure, atrial fibrillation, congestive heart failure, and thyrotoxic cardiomyopathy after treatment (p<0.01).
- Anti-TSH receptor antibodies identified as predictors of left ventricular geometry changes (p=0.02).
- HRQoL domains and self-rated health significantly improved (p<0.001).
Conclusions:
- Achieving a euthyroid state in GD patients effectively eliminates cardiovascular disorders.
- Treatment of THD secondary to GD substantially enhances patient HRQoL.
- This study provides novel insights into HRQoL among Ukrainian patients with THD secondary to GD.
Background:
Graves' disease (GD) is a common cause of hyperthyroidism resulting in development of thyrotoxic heart disease (THD).
Objectives:
to assess cardiovascular disorders and health related quality of life (HRQoL) in patients with THD secondary to GD.
Patients And Methods:
All patients diagnosed with THD secondary to GD between January 2011 and December 2013 were eligible for this study. Clinical assessment was performed at baseline and at the follow-up visit after the restoring of euthyroid state. HRQoL was studied with a questionnaire EQ-5D-5L.
Results:
Follow-up data were available for 61 patients, but only 30 patients with THD secondary to GD were consented to participate in investigation of their HRQoL. The frequency of cardiovascular complications was significantly reduced as compared before and after the antithyroid therapy as follows: resting heart rate (122 vs. 74 bpm), blood pressure: systolic (155 vs. 123 mm Hg), diastolic (83 vs. 66 mm Hg), supraventricular premature contractions (71% vs. 7%), atrial fibrillation (72% vs. 25%), congestive heart failure (69% vs. 20%), thyrotoxic cardiomyopathy (77% vs. 26%), all p<0.01. Anti-TSH receptor antibodies were determined as independent predictor of left ventricular geometry changes, (b-coefficient = 0.04, 95%CI 0.01-0.07, p = 0.02). HRQoL was improved in all domains and self-rated health increased from 43 to 75 units by visual analogue score (p<0.001).
Conclusions:
Restoring of euthyroid state in patients with GD is associated with significant elimination of cardiovascular disorders and improvement of HRQoL. To our knowledge this is the first study evaluating Ukrainian patients with THD secondary to GD with focus on HRQoL.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hyperthyroidism I: Introduction
Hyperthyroidism II: Pathophysiology
Graves' Disease I: Introduction
Graves Disease II: Pathophysiology
Hypothyroidism II: Pathophysiology

